Patent · US Active

Extended release biodegradable ocular implants

US10154960B2 · kind B2 · utility

0Cited by

24References

3Claims

0Family size

Assignee

Allergan, Inc. · US

Inventors

Thierry Nivaggioli · San Francisco, US
James Jane-Guo Shiah · Irvine, US
Qing Lin · San Diego, US

Key dates

Filing date	Jan 30, 2015
Grant date	Dec 18, 2018
Priority date	—
Expiry date	Jan 30, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/204
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.